Frontlight ResearchEarly access
Gastric and oesophageal cancer trials in China
723 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleAI-assisted Endoscopic Ultrasound Grading of Early Esophageal Cancer Invasion Depth: A Multicenter, Prospective, Randomized Cohort Study
- Where
- Fuzhou, Putian
- Age
- 18 years and over
- People
- 200
- Run by
- Fujian Provincial Hospital
See details and how to joinNCT07251114 - Phase 2/3Taking peopleUtidelone Capsule Combined With Fluoropyrimidine- and Platinum-containing Therapy in First-line Treatment of Patients With Gastric or Gastroesophageal Junction Adenocarcinoma
- Where
- Anyang, Guangzhou, Jinan, Shenyang, Taiyuan, Tianjin, Wuhan, Zhengzhou
- Age
- 18 years and over
- People
- 778 worldwide
- Run by
- Beijing Biostar Pharmaceuticals Co., Ltd.
See details and how to joinNCT06841679 - Phase 2Taking peopleIntestinal Low Dose Radiotherapy Combined With Immunotherapy in Immune-resistant Metastatic Malignant Solid Tumors
- Where
- Shantou
- Age
- 18 years to 80 years
- People
- 48
- Run by
- Chuangzhen Chen
See details and how to joinNCT07071103 - Phase 1/2Taking peopleA Study of AK109 and AK104 in Advanced Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma
- Where
- Beijing
- Age
- 18 years to 75 years
- People
- 138
- Run by
- Akeso
See details and how to joinNCT04982276 - Phase 1/2Taking peopleIntraperitoneal Immune Checkpoint Inhibitors and Zoledronic Acids for Gastric Cancer Malignant Ascites
- Where
- Jinan
- Age
- 18 years to 75 years
- People
- 24
- Run by
- Qilu Hospital of Shandong University
See details and how to joinNCT06759064 - No phaseTaking peoplePPG vs. ICG in Gastrointestinal Resections
- Where
- Yantai
- Age
- 18 years and over
- People
- 200 worldwide
- Run by
- Saint Petersburg State University, Russia
See details and how to joinNCT06222645 - Phase 2Taking peoplePhase II, Open-label, Multicenter Study to Evaluate the Efficacy and Safety of HLX43 (an Anti-PD-L1 ADC) in Subjects With Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
- Where
- Beijing
- Age
- 18 days to 75 days
- People
- 60
- Run by
- Shanghai Henlius Biotech
See details and how to joinNCT07115485 - Phase 2Not yet taking people in ChinaA Phase II Clinical Study Evaluating SSGJ-706 in Combination Therapy for Advanced Gastrointestinal Cancers
- Where
- Wuhan
- Age
- 18 years to 75 years
- People
- 300
- Run by
- Shenyang Sunshine Pharmaceutical Co., LTD.
See details and how to joinNCT07233850 - Phase 2Taking peopleHypofractionated vs. Conventional Chemoradiotherapy After Induction Chemo-immunotherapy for Unresectable Esophageal Squamous Cell Carcinoma
- Where
- Guangzhou
- Age
- 18 years to 80 years
- People
- 134
- Run by
- Sun Yat-sen University
See details and how to joinNCT06912074 - Phase 2Taking peopleSurufatinib in Combination With Neoadjuvant Chemo-immunotherapy and Concurrent Chemoradiotherapy for Patients With Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma
- Where
- Guangzhou
- Age
- 18 years to 80 years
- People
- 69
- Run by
- Sun Yat-sen University
See details and how to joinNCT07086469 - Phase 3Taking peopleA Study of BL-M07D1 Versus Investigator's Choice of Chemotherapy in Patients With HER2-positive Locally Advanced or Metastatic Gastric or Gastro-esophageal Junction Adenocarcinoma
- Where
- Harbin, Shanghai
- Age
- 18 years to 75 years
- People
- 490
- Run by
- Sichuan Baili Pharmaceutical Co., Ltd.
See details and how to joinNCT07152405 - Phase 3Taking peopleA Phase III Randomized Study in CLDN18.2-positive Unresectable Locally Advanced Gastric Cancer Patients
- Where
- Beijing
- Age
- 18 years and over
- People
- 150
- Run by
- Suzhou Immunofoco Biotechnology Co., Ltd
See details and how to joinNCT07103668 - Phase 2Taking peopleThe Safety and Clinical Efficacy of RAK Cell Therapy in Late-stage Gastric Cancer: A Randomized Controlled Trial
- Where
- Beijing
- Age
- 18 years to 70 years
- People
- 90
- Run by
- Chinese PLA General Hospital
See details and how to joinNCT07212933 - Phase 2Taking peopleA Single-arm, Open, Single-center Exploratory Study of Adebrelimab (SHR-1316) in Combination With Chemotherapy for the Perioperative Treatment of Locally Advanced Resectable Esophageal Squamous Carcinoma
- Where
- Beijing
- Age
- 18 years to 75 years
- People
- 30
- Run by
- Peking University Cancer Hospital & Institute
See details and how to joinNCT06869213 - Phase 2Taking peopleA Multicenter Phase II Clinical Study of Neoadjuvant Use of Camrelizumab in Combination With Chemotherapy for Organ Preservation in Esophageal Cancer
- Where
- Beijing
- Age
- 18 years to 75 years
- People
- 283
- Run by
- Peking University Cancer Hospital & Institute
See details and how to joinNCT06869226 - Phase 1Taking peopleCEA-Targeted CAR-T Therapy in CEA-Positive Advanced Solid Tumors
- Where
- Hefei
- Age
- 18 years and over
- People
- 108
- Run by
- Chongqing Precision Biotech Co., Ltd
See details and how to joinNCT07179692 - No phaseTaking peopleTo Evaluate the Efficacy of CT041 in Sequential Treatment After First-line Treatment of Advanced Gastric/Esophagogastric Junction Adenocarcinoma
- Where
- Beijing
- Age
- 18 years to 75 years
- People
- 20
- Run by
- Beijing GoBroad Hospital
See details and how to joinNCT07179484 - No phaseTaking peopleComparation of Endoscopic Biopsy and Postoperative Specimen for the Molecular Diagnosis of Gastric Cancer
- Where
- Shanghai
- Age
- 18 years to 75 years
- People
- 510
- Run by
- Fudan University
See details and how to joinNCT04809025 - Phase 1/2Not yet taking people in ChinaTAS-102 Plus Radiotherapy in Elderly ESCC
- Where
- Jinan
- Age
- 65 years to 85 years
- People
- 45
- Run by
- Qianfoshan Hospital
See details and how to joinNCT07196345 - Phase 2Taking peopleA Study of SI-B003, BL-B01D1+SI-B003 and BL-B01D1+PD-1 Monoclonal Antibody in Patients With Locally Advanced or Metastatic Esophageal Cancer, Gastric Cancer, Colorectal Cancer and Other Gastrointestinal Tumors
- Where
- Beijing
- Age
- 18 years to 75 years
- People
- 376
- Run by
- Sichuan Baili Pharmaceutical Co., Ltd.
See details and how to joinNCT06008054 - Phase 2Taking peopleConversion Therapy With RC48, Sintilimab, and SOX for HER2 1+/2+ Unresectable Gastric Cancer
- Where
- Shanghai
- Age
- 18 years to 70 years
- People
- 30
- Run by
- Fudan University
See details and how to joinNCT07194005 - Phase 2Taking peopleIvonescimab Plus Short-Course Hypofractionated Radiotherapy as Second-Line Therapy for Esophageal Squamous Cell Carcinoma
- Where
- Hefei
- Age
- 18 years to 80 years
- People
- 37
- Run by
- Anhui Provincial Hospital
See details and how to joinNCT07188103 - No phaseTaking peopleMulticenter Study on Laparoscopic Total Gastrectomy for Advanced Gastric Cancer
- Where
- Shanghai
- Age
- 18 years to 75 years
- People
- 1,018
- Run by
- Shanghai Zhongshan Hospital
See details and how to joinNCT04710758 - No phaseEnrolling by invitationTemporal Transformation Mechanism and Intervention Strategies of Frail-related Dietary Behaviors in Older Gastric Cancer Survivors
- Where
- Nanjing
- Age
- 60 years and over
- People
- 438
- Run by
- Nanjing Medical University
See details and how to joinNCT07176455 - No phaseTaking peopleThe Possible Range of No.4sb Lymph Node Dissection of Locally Advanced Distal Gastric Cancer
- Where
- Tianjin
- Age
- 18 years to 80 years
- People
- 400
- Run by
- Tianjin Medical University Cancer Institute and Hospital
See details and how to joinNCT07183150